IMULAN has conducted clinical studies in cats with stomatitis (feline lymphocytic plasmacytic stomatitis) with encouraging results. Data have been previously presented at the American Veterinary Dental Forum and the American Academy of Veterinary Pharmacology and Therapeutics Symposium.
Based on pathophysiology, IMULAN is also interested in exploring the following conditions for our TCR peptide therapeutic:
Feline Leukemia Virus (FeLV)
Feline Immunodeficiency Virus (FIV)
Feline Infectious Peritonitis (FIP)